FDA applicant
Life Technologies Corporation
FDA records 14 decisions for Life Technologies Corporation (Grand Island, NY) from 1995 to 2026: 11 510(k) clearances, 1 De Novo grant and 2 original PMA approvals. Most are in product codes NDS (Media, Culture, Ex Vivo, Tissue And Cell) and PQP (Next Generation Sequencing Oncology Panel…). Its devices cite 7 predicates, 1 of them its own earlier devices. 12 recalls are linked to its devices.
FDA’s records also spell it “Life Technologies, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Life Technologies Corporation’s devices, and how often a recall has named them.
FDA decisions per year
2in 2025
2026 so far, outlined.
Recalls per year
4in 2020
Class I Class II/III not classified
Planning a device like Life Technologies Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report